CID 131751333

4,5-dihydroniveusin a

Structural Information

Molecular Formula
C20H28O8
SMILES
C/C=C(/C)\C(=O)OC1CC2(C(CC(O2)(C(CC3C1C(=C)C(=O)O3)CO)O)O)C
InChI
InChI=1S/C20H28O8/c1-5-10(2)17(23)27-14-7-19(4)15(22)8-20(25,28-19)12(9-21)6-13-16(14)11(3)18(24)26-13/h5,12-16,21-22,25H,3,6-9H2,1-2,4H3/b10-5-
InChIKey
SNUZCOSRHAIVKC-YHYXMXQVSA-N
Compound name
[1,12-dihydroxy-2-(hydroxymethyl)-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.04,8]tetradecan-9-yl] (Z)-2-methylbut-2-enoate
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

396.1784 Da
Monoisotopic Mass

1.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 397.18568 218.6
[M+Na]+ 419.16762 218.6
[M-H]- 395.17112 217.7
[M+NH4]+ 414.21222 217.8
[M+K]+ 435.14156 216.7
[M+H-H2O]+ 379.17566 209.3
[M+HCOO]- 441.17660 218.0
[M+CH3COO]- 455.19225 218.0
[M+Na-2H]- 417.15307 217.8
[M]+ 396.17785 217.7
[M]- 396.17895 217.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.